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ABSTRACT
Infants with persistent wheeze is a common diagnostic challenge for the general 
pediatrician because of the broad differential diagnoses. The initial diagnostic ap-
proach should include a comprehensive history, physical examination, and chest ra-
diography. Additional testing may be warranted. Involvement of a pediatric pulmo-
nary subspecialist may also be indicated. [Pediatr Ann. 2019;48(3):e110-e114.]
Wheeze is one of the most common respiratory symp-toms in the pediatric popu-
lation. The Tucson Children’s Respi-
ratory Study (TCRS), a longitudinal 
birth cohort study of healthy full-term 
infants, demonstrated that 34% of 
children had at least one episode of 
wheeze before age 3 years and 50% of 
children wheezed in the first 6 years 
of life.1 Similarly, a large prospective, 
population-based longitudinal birth 
cohort study in Sweden found that 
25% of children wheezed before age 
2 years.2
Several risk factors have been im-
plicated in recurrent or persistent 
wheeze, typically defined as three or 
more episodes of wheeze in 1 year 
(Table 1).1,3 Although multiple risk 
factors are associated with persistent 
and recurrent wheeze, the “Estudio 
Internacional de Sibilancias en Lac-
tantes [International Study of Wheez-
ing in Infants]” (EISL), a population-
based study in Latin America and 
Europe, showed that nursery school 
attendance and colds during the first 
3 months of life were the most im-
portant risk factors.3 The EISL also 
found that breast-feeding for more 
than 3 months was a protective factor 
against wheezing.3
DIAGNOSIS AND MANAGEMENT
The initial history should include 
a detailed account of the wheezing 
episodes, including onset, frequency, 
duration, and associated palliative 
and provoking factors. Birth history 
(eg, prematurity, respiratory distress 
at birth), medical history (eg, eczema, 
allergic rhinitis), family history (eg, 
atopy, asthma), and environmental 
history (eg, cigarette smoke exposure, 
day care attendance) are also impor-
tant to review. Physical examination 
should include evaluation of respira-
tory rate and oxygen saturation, in 
addition to a thorough respiratory as-
sessment.4 
With regards to diagnostic test-
ing, an initial chest radiograph with 
posteroanterior and lateral views is 
recommended.4 Further diagnostic 
testing may not be needed for in-
fants whose wheeze responds well 
to commonly used therapies such as 
bronchodilators and inhaled cortico-
steroids. However, as outlined below, 
more advanced testing may be needed 
for infants who do not respond to con-
ventional therapy.5
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DIFFERENTIAL DIAGNOSES
The most common causes of persis-
tent and recurrent wheeze include in-
fections, asthma, allergies, and gastro-
esophageal reflux disease. However, 
the differential for infantile wheeze is 
broad and includes protracted bacteri-
al bronchitis, anatomic abnormalities, 
swallowing dysfunction, and others.5 
A referral to a pediatric pulmonary 
subspecialist may be helpful to help 
establish the diagnosis and facilitate 
any needed testing.
INFECTIONS
Viral infections are one of the most 
common causes of wheeze in infancy. 
The TCRS demonstrated that in the 
first year of life, the prevalence of 
wheezing with lower respiratory ill-
nesses was 32%.6 The TRCS also 
showed that this was 17.3% in the sec-
ond year of life and 12% in the third 
year of life.6
Risk factors for wheezing with 
lower respiratory illnesses include 
maternal smoking and maternal age. 
Maternal smoking is associated with 
earlier age of first lower respiratory 
illness and increased incidence of 
wheezing with lower respiratory ill-
ness.6,7 Younger maternal age is as-
sociated with an increased incidence 
of wheeze with lower respiratory tract 
illnesses.6,8 Breast-feeding is a protec-
tive factor in the first 4 months of life 
for wheezing associated with respira-
tory illnesses.6,9
Bronchiolitis was the most com-
monly diagnosed initial lower respi-
ratory tract infection in the TCRS.10 
Bronchiolitis typically presents with 
rhinorrhea, cough, wheeze, tachy-
pnea, retractions and increased work 
of breathing.11 It is often diagnosed 
based on history and clinical presenta-
tion. Virologic testing is not routinely 
recommended.11 Chest radiography in 
acute bronchiolitis is reserved for in-
fants admitted to the intensive care unit 
or with pulmonary complications.11
Respiratory syncytial virus (RSV) is 
the most common viral cause of bron-
chiolitis.11 Other viral etiologies of 
bronchiolitis include human rhinovirus, 
human metapneumovirus, influenza, 
adenovirus, coronavirus, and parainflu-
enza virus.11 RSV infection before age 
3 years is associated with an increase 
in subsequent wheezing in the first 10 
years of life, but not an increase in asth-
ma prevalence at age 13 years.12
The mainstay of treatment for bron-
chiolitis is supportive care. Albuterol, 
epinephrine, systemic corticosteroids, 
and chest physiotherapy are no longer 
recommended in the absence of other 
conditions.11 Nebulized hypertonic 
saline is advised only for treatment in 
hospitalized infants.11 
ASTHMA
Asthma is one of the most common 
etiologies of persistent wheezing in 
children. It is also the most common 
chronic medical disease in the pediat-
ric population and a leading cause of 
hospitalization.13 Uncontrolled asthma 
results in significant morbidity, mortal-
ity, and health care costs in children.13
The diagnosis of asthma in infants 
can be challenging, particularly when 
trying to distinguish it from viral-me-
diated wheeze. Because there is no test 
available that can easily diagnose asth-
ma, the diagnosis is often made based 
on symptom history, family history, and 
physical examination findings. Symp-
toms characteristic of asthma include 
wheeze, nonproductive cough, short-
ness of breath, and activity limitation. 
Adjunctive clinical tests can also be 
helpful in diagnosis. The Global Ini-
tiative for Asthma guidelines note the 
following to be useful diagnostic aids: 
therapeutic trial of inhaled corticoste-
roids and as needed short-acting beta2-
agonists, atopy testing, chest radiog-
raphy, lung function testing (in older 
children), measuring exhaled nitric 
oxide, and asthma predictive indices.14 
The Asthma Predictive Index (API) 
(Table 2) was developed to aid in the 
early identification of children at high 
risk for developing asthma. It has been 
shown that 68% of school-aged chil-
dren with a negative API did not de-
velop asthma, whereas 76% of children 
with a positive API had symptoms of 
asthma at least once between ages 6 and 
13 years.6,15
Since the API was developed, other 
predictive models have been created. 
The modified Asthma Predictive Index 
(mAPI) (Table 3) is one such clinical 
tool. The mAPI is for use in children 
younger than age 3 years and with more 
than four wheezing episodes per year.16 
A study demonstrated that a positive 
mAPI increased the probability of fu-
ture asthma diagnosis.16 It should be 
noted that all of these indices were cre-
ated to predict future asthma and not 
the clinical response to asthma thera-
pies in infants.
If the clinician suspects asthma and 
respiratory symptoms are frequent or 
TABLE 1.
Risk Factors for Persistent 
Wheeze 
Nursery school attendance
Rhinitis apart from colds
Colds during the first 3 months of life
Eczema during the first year of life
Maternal smoking 




Adapted from Martinez et al.1 and Garcia-Marcos et al.3
uncontrolled, current guidelines recom-
mend initiating controller therapy.14,17 
Asthma treatment in children should 
follow a stepwise approach. Inhaled 
short-acting beta2-agonists are used 
for symptomatic relief. When starting 
asthma controller therapy, an inhaled 
corticosteroid is the preferred initial 
treatment. Response to therapy should 
be closely monitored. After 3 months 
of well-controlled symptoms, a step-
down in treatment may be considered. 
Consider a step-up in therapy, if symp-
toms are persistent 4 to 6 weeks after 
beginning treatment, but only after 
differential diagnosis, medication ad-
herence, and correct inhaler technique 
are reviewed.17 If further increases in 
asthma therapy are considered, a refer-
ral to a pediatric asthma specialist is 
recommended.
ALLERGIES
Allergies are one consideration in 
persistent wheeze in infancy. The Gen-
eration R Study found no significant 
association between early introduction 
of cow’s milk, peanuts, soy, gluten, and 
hen’s egg with wheezing at any age.18 
The American Thoracic Society (ATS) 
clinical practice guidelines do not rec-
ommend empiric food avoidance in 
“infants without eczema who have per-




Gastroesophageal reflux disease 
(GERD) is a common cause of persis-
tent wheezing. In a study of children 
younger than age 2 years with recurrent 
and persistent wheezing, GERD con-
tributed to wheeze in 37% of patients.19
Although wheeze is one common 
symptom of GERD, other associated 
symptoms include cough, feeding re-
fusal, discomfort, dysphagia, failure 
to thrive, Sandifer syndrome, recurrent 
regurgitation, stridor, and hoarseness.20
Recent clinical guidelines from ATS 
recommend 24-hour esophageal pH 
monitoring for “infants with persistent 
wheeze that is not relieved by bron-
chodilators, inhaled corticosteroids, 
or systemic corticosteroids.”5 Studies 
such as barium contrast studies, ultra-
sonography, esophago-gastro-dudode-
noscopy, and scintigraphy are not rec-
ommended for the diagnosis of GERD 
in infants.5,20 Previously empiric trials 
of anti-reflux therapy were given but 
this is no longer advised in infants.20 
Instead, the Pediatric Gastroesophageal 
Reflux Clinical Practice Guidelines 
suggest thickening feeds and adjusting 
feeding frequency and volume to avoid 
overfeeding.20 If these interventions are 
unsuccessful, consider a 2- to 4-week 
trial of amino-acid–based or extensive-
ly hydrolyzed protein-based formula. 
If nonpharmacologic treatments fail to 




Another cause of wheezing in in-
fancy is protracted bacterial bronchitis 
(PBB). This diagnosis is characterized 
by the presence of a chronic wet or pro-
ductive cough for greater than 4 weeks 
that resolves with a 2- to 4-week course 
of an appropriate oral antibiotic.21 Al-
though chronic cough is the defining 
symptom in PBB, wheezing has also 
been reported.21 ATS guidelines also 
recommend bronchoscopy with bron-
choalveolar lavage (BAL) in infants 
with persistent wheeze despite stan-
dard therapies.5 Common broncho-
scopic findings in children with PBB 
include airway malacia, bronchitis, 
and purulent secretions.21,22 The most 
common bacterial pathogens detected 
in BAL cultures from children diag-
nosed with PBB include Haemophilus 
influenzae, Streptococcus pneumoni-
ae, and Moraxella catarrhalis.21 Man-
agement of PBB is typically a 2- to 
4-week course of an appropriate oral
antibiotic, although the 2008 British
Thoracic Society guidelines suggested
a 4- to 6-week course of antibiotics
and chest physiotherapy for children
with PBB.22,23
SWALLOWING DYSFUNCTION
Swallowing dysfunction is another 
cause of persistent wheezing in infancy. 
TABLE 2. 
Asthma Predictive Index
Major Criteria  
(at least 1 major)
Minor Criteria  


















Major Criteria  
(at least 1 major)
Minor Criteria  





tion to at least one 
aeroallergen 
Parental history of 
asthma
Allergic sensitiza-






Adapted from Change et al.16
Sheikh et al.24 described 13 neurologi-
cally normal infants with chronic re-
spiratory symptoms secondary to as-
piration. Their respiratory symptoms 
resolved once their aspiration resolved.24 
Studies have reported that 10% to 15% 
of infants with respiratory symptoms but 
not a chronic illness have swallowing 
dysfunction.5
Other signs and symptoms of aspira-
tion include coughing, choking and/or 
gagging during feeding, apnea, brady-
cardia, recurrent pneumonia or bronchi-
tis, and failure to thrive.24 Recent ATS 
guidelines recommend swallow func-
tion study in “infants without neurologic 
pathology with persistent wheeze that is 
not relieved by bronchodilators, inhaled 
corticosteroids or systemic corticoste-
roids.”5 Treatment often includes chang-
es to the feeding regimen.24
FOREIGN BODY ASPIRATION
Although rare, foreign body aspira-
tion can be one explanation for persis-
tent wheeze. One study showed that 
wheezing was a common symptom and 
physical examination finding in chil-
dren hospitalized with suspected foreign 
body aspiration.25 Chest radiography 
should be obtained in children with sus-
pected foreign body aspiration.26 Man-
agement is rigid bronchoscopic removal 
of the aspirated foreign body.26
ANATOMIC ABNORMALITIES
Anatomic abnormalities can cause 
persistent wheezing, although this is 
more prevalent in infants who have 
failed standard therapies. In a study of 
603 children with chronic respiratory 
symptoms who underwent broncho-
scopic evaluation, 34 (5.6%) had tra-
cheomalacia and/or bronchomalacia.27 
Other anatomic abnormalities that may 
present with wheeze include vascular 
rings, vascular slings, and airway com-
pression by vascular structures.5 ATS 
recommends flexible bronchoscopy in 
infants with persistent wheeze who have 
failed conventional therapies.5 If air-
way evaluation reveals tracheomalacia 
and/or bronchomalacia, management is 
often observation, although occasion-
ally intervention is indicated.5 If a vas-
cular ring, a vascular sling, or airway 
compression due to vascular structures 
is seen, surgical correction is often per-
formed on symptomatic patients.5
CYSTIC FIBROSIS
Cystic fibrosis (CF) is a rare cause of 
wheezing in infants. It is a life-limiting 
autosomal recessive disorder resulting 
from mutation of the CF transmembrane 
conductance regulator (CFTR) gene.28 
Clinical presentation varies depending 
on the CF genotype, but can include 
failure to thrive, recurrent respiratory in-
fections, and decreased lung function.29 
The majority of new CF diagnoses are 
the result of positive newborn screen 
(NBS).28 Although NBS allows for early 
diagnosis, confirmation of the diagnosis 
with a sweat chloride test is still recom-
mended.28 A positive sweat chloride test 
will demonstrate elevated sweat chloride 
concentration indicative of a CFTR de-
fect.28 Children with CF should be treat-
ed at an accredited CF center.29 
PRIMARY CILIARY DYSKINESIA
Primary ciliary dyskinesia (PCD) is 
another rare cause of wheezing in in-
fants. PCD is an autosomal recessive 
disorder characterized by motile cili-
ary dysfunction. Characteristic findings 
include daily wet productive cough, 
daily rhinosinusitis, history of neonatal 
respiratory distress syndrome, and or-
gan laterality defects.30 Chronic otitis 
media with effusion is also often seen 
in PCD.30 Diagnostic testing includes 
nasal nitric oxide measurement, genetic 
testing, and electron microscopy of cili-
ary ultrastructure.30 Children with PCD 
should be managed at a PCD foundation 
clinical center or by a multidisciplinary 
team at an accredited CF center.31
CONCLUSION
In summary, persistent wheezing in 
infants is a commonly encountered com-
plaint with multiple etiologies. Although 
respiratory viral infections and asthma 
represent the most common etiologies, 
other diagnoses should be considered for 
infants who do not respond to standard 
therapies. A detailed history, thorough 
physical examination, and chest radiog-
raphy will help narrow the differential 
diagnoses. Further evaluation should be 
tailored to the likely etiology. Consulta-
tion with a pediatric pulmonary subspe-
cialist may also be warranted depending 
on severity of respiratory symptoms and 
suspected etiology.
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